Form 4 for INSM INSMED Inc
Accepted 2024-05-15 00:00:00 ET · period of report 2024-05-13 · accession 0001628280-24-023598 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-15 | 2024-05-13 | INSM | Flammer Martina M.D. | Chief Medical Off | A - Grant | — | +14.5K | 121.4K | +14% | — |
| D | 2024-05-15 | 2024-05-14 | INSM | Flammer Martina M.D. | Chief Medical Off | S - Sale | $25.47 | -10.6K | 110.8K | -9% | -$271.0K |
| D | 2024-05-15 | 2024-05-13 | INSM | Flammer Martina M.D. | Chief Medical Off | A - Grant | $0.00 | +71.2K | 71.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-13 | A | A | 14,518 | — | 121,416 | D | — | — | (F1) Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% percent on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested. (F2) Each RSU was granted on May 13, 2024 for no consideration. |
| 2 | Common | Common Stock | 2024-05-14 | S | D | 10,640 | $25.47 | 110,776 | D | — | — | (F3) Shares sold to satisfy withholding tax obligations upon the vesting of RSUs and to cover related broker fees. (F4) This is the weighted average sales price representing 10,640 shares sold at prices ranging from $25.42 to $25.52 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 3 | Derivative | Stock Option (right to buy) | 2024-05-13 | A | A | 71,160 | $0.00 | 71,160 | D | $25.83 · — to 2034-05-13 | 71,160 Common Stock | (F5) These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter through the fourth anniversary of the Initial Vesting Date. |